Á÷Ã¥ | ¼ºÇÔ | ¼Ò¼Ó ¹× Á÷À§ |
---|---|---|
ÆíÁýÀ§¿øÀå | ±è¿µ¼· | ´Ü±¹´ëÇб³ ±³¼ö |
ÆíÁýÀÌ»ç | ±èÁ¤±æ | ³²¼¿ï´ëÇб³ ±³¼ö |
¹ÚÁ¦È£ | ´Ü±¹´ëÇб³ ±³¼ö | |
¹ÚÇüÈ£ | ¿¬¼¼´ëÇб³ ±³¼ö | |
¼Òº´¹® | ÀüºÏ´ëÇб³ ±³¼ö | |
½ÉÇö½Ä | °æ±â´ëÇб³ ±³¼ö | |
À±°æ·Î | °Ç±¹´ëÇб³ ±³¼ö | |
ÀÌ¿ëȯ | ¿ø±¤´ëÇб³ ±³¼ö | |
ÀÌÁØÇÏ | »ó¸í´ëÇб³ ±³¼ö | |
Á¤È£¿ | ¿µ³²´ëÇб³ ±³¼ö | |
ÇÑ°æÁØ | Biothlon Inc. CTO | |
Çö±¤ÀÍ | ¿ÉÅä´ÙÀ̳ª¹Í½º CEO | |
G.P.Li | UC Irvine Prof. | |
ÆíÁýÀ§¿ø | °û¿µÅ | ÀüºÏ´ëÇб³ ±³¼ö |
·ù»ó¿í | ´Ü±¹´ëÇб³ ±³¼ö | |
±è°üµµ | ÆòÅôëÇб³ ±³¼ö | |
±è°æȯ | °¡Ãµ´ëÇб³ ±³¼ö | |
±è±¹¿ø | ¼øõÇâ´ëÇб³ ±³¼ö | |
±è±ÙÁÖ | ÀüºÏ´ëÇб³ ±³¼ö | |
±èµ¿À± | ¿¬¼¼´ëÇб³ ±³¼ö | |
±èµÎ¿ë | ¼øõÇâ´ëÇб³ ±³¼ö | |
¹ÚÀ¯Áø | Áß¾Ó´ëÇб³ ±³¼ö | |
¼ÛÀ±È£ | ÀüÀÚÅë½Å¿¬±¸¿ø Ã¥ÀÓ¿¬±¸¿ø | |
À±ÀÇÁß | È£¼´ëÇб³ ±³¼ö | |
À̱³¿ì | ÀüºÏ´ëÇб³ ±³¼ö | |
À̱Կµ | °¿ø´ëÇб³ ±³¼ö | |
ÀÓÀÍÅ | ÀüºÏ´ëÇб³ ±³¼ö | |
À念ö | Çѱ¹±â¼ú±³À°´ëÇб³ ±³¼ö | |
ÀüÀÇ½Ä | °øÁÖ´ëÇб³ ±³¼ö | |
Á¶±Ô»ó | µ¿¾ç´ëÇб³ ±³¼ö | |
Á¶ÇöÂù | Çѱ¹±â¼ú±³À°´ëÇб³ ±³¼ö | |
ÁÖÁ¤ÈÆ | ±º»ê´ëÇб³ ±³¼ö | |
Áø°æº¹ | Çѱ¹±â¼ú´ëÇб³ ±³¼ö | |
ÇÑöÈñ | Çѱ¹±³Åë´ëÇб³ ±³¼ö |